Login / Register Order My Items
mob-logo
Contact Us
800.227.0627
Contact Us Quote Order Login / Register

Inverted Base Modified Oligonucleotides

Custom inverted base modified oligos containing 3′–3′ and 5′–5′ reverse-polarity linkages, including inverted dT, inverted ddT, inverted DNA bases, RNA bases, 2′-O-methyl bases, inverted abasic residues, reverse synthesis and reverse spacer designs.

3′ Inverted dT 5′ Inverted ddT 3′–3′ Linkages 5′–5′ Linkages Reverse Synthesis DNA / RNA / 2′-OMe
Request Design Review View Product Table
Overview Linkages Products Reverse Synthesis Design Applications Quality Related FAQ Contact Reading
Overview

Reverse-Polarity Oligos for Blocking, Stability and Backbone Engineering

Inverted base modified oligonucleotides contain one or more nucleotides incorporated in the reverse orientation relative to the normal 5′→3′ nucleic acid backbone. Instead of a standard phosphodiester connection, the inverted residue can create a 3′–3′ or 5′–5′ reverse-polarity linkage. These structures are commonly used when the oligo must resist enzymatic degradation, block polymerase extension, prevent unwanted ligation or create a non-natural backbone architecture for nucleic acid research.

Examples of reverse-polarity oligonucleotide building blocks including inverted DNA, inverted RNA, inverted 2′-O-methyl RNA and inverted abasic site.

Figure 1. Examples of reverse-polarity phosphoramidite building blocks used for the synthesis of inverted DNA, inverted RNA, inverted 2′-O-methyl RNA, and inverted abasic-site modified oligonucleotides. These reverse-oriented monomers enable the formation of 3′–3′ and 5′–5′ linkages during oligonucleotide synthesis.

The most familiar example is 3′ inverted dT, often written as /3InvdT/. This terminal modification removes the normal extendable 3′-OH architecture and is widely used in probes, blocking oligos, sequencing adapters, antisense designs and nuclease-resistance studies. A related product, 5′ inverted dideoxy-T, is useful when a 5′ reverse-polarity cap or adapter-blocking feature is required.

Inverted bases are different from 2′→5′ linked oligonucleotides. A 2′→5′ linkage changes which hydroxyl group forms the phosphodiester bond while the nucleotide orientation remains generally forward. An inverted base changes the polarity of a nucleotide or segment, producing reverse-polarity linkages such as 3′–3′ or 5′–5′.

Capability note: Bio-Synthesis can support many inverted base and reverse-polarity oligo designs. Some specialty modifications may require custom reagent preparation, sequence feasibility review or process development.

LINKAGE CONCEPT

Natural 5′→3′ vs 3′–3′ and 5′–5′ Reverse-Polarity Linkages

Inverted modifications are best understood as polarity changes in the oligonucleotide backbone. A terminal inverted residue can block polymerase extension; an internal inverted segment can create a deliberate structural discontinuity.

Backbone Polarity Comparison

standard linkage vs inverted polarity
Natural 5′→3′ Direction
5′ P 3′

Standard DNA and RNA polarity. A free 3′ end may be extendable by polymerases.

3′–3′ Inverted Linkage
5′ 3′ P 3′

Typical terminal blocking architecture for 3′ inverted nucleotides such as 3′ inverted dT.

5′–5′ Inverted Linkage
5′ P 5′ 3′

Reverse-polarity architecture used for 5′ inverted nucleotides and specialized constructs.

Supported Product Families

Inverted Base and Reverse-Polarity Product Families

Select a product family to compare representative inverted modifications, bracketed example sequence codes, reverse-polarity linkages and typical applications.

Click a product family to explore supported modifications

Details below

Inverted DNA Bases

Reverse-polarity DNA modifications including dA, dC, dG, dT, dU, deoxyinosine and 5-methyl-dC.

Modification Example Sequence Code Sugar / Scaffold Base Linkage Typical Applications
3′ Inverted dA [3Inv-dA] Deoxyadenosine A 3′–3′ Reverse-polarity DNA, terminal or internal design studies
5′ Inverted dA [5Inv-dA] Deoxyadenosine A 5′–5′ Reverse-polarity DNA and 5′ architecture studies
3′ Inverted dC [3Inv-dC] Deoxycytidine C 3′–3′ Reverse-polarity DNA, nuclease-resistance studies
5′ Inverted dC [5Inv-dC] Deoxycytidine C 5′–5′ Reverse-polarity DNA and specialty constructs
3′ Inverted dG [3Inv-dG] Deoxyguanosine G 3′–3′ Reverse-polarity DNA, structure-function studies
5′ Inverted dG [5Inv-dG] Deoxyguanosine G 5′–5′ Reverse-polarity DNA and specialty constructs
3′ Inverted dT [3Inv-dT] Deoxythymidine T 3′–3′ 3′ blocker for probes, adapters, antisense and exonuclease resistance
5′ Inverted dT [5Inv-dT] Deoxythymidine T 5′–5′ Reverse-polarity constructs and terminal architecture control
3′ Inverted dU [3Inv-dU] Deoxyuridine U 3′–3′ Specialty DNA designs where thymidine is not preferred
5′ Inverted dU [5Inv-dU] Deoxyuridine U 5′–5′ Specialty reverse-polarity DNA designs
3′ Inverted deoxyinosine [3Inv-dI] Deoxyinosine I 3′–3′ Universal-base and pairing studies
5′ Inverted deoxyinosine [5Inv-dI] Deoxyinosine I 5′–5′ Reverse-polarity universal-base studies
3′ Inverted 5-methyl-dC [3Inv-5mdC] 5-methyl-deoxycytidine 5mC 3′–3′ Epigenetic analog and modified-base studies
5′ Inverted 5-methyl-dC [5Inv-5mdC] 5-methyl-deoxycytidine 5mC 5′–5′ Specialty epigenetic analog constructs

Inverted RNA Bases

Reverse-polarity RNA modifications using rA, rC, rG and rU building blocks.

Modification Example Sequence Code Sugar / Scaffold Base Linkage Typical Applications
3′ Inverted rA [3Inv-rA] Adenosine A 3′–3′ RNA reverse-polarity and folding studies
5′ Inverted rA [5Inv-rA] Adenosine A 5′–5′ RNA reverse-polarity architecture
3′ Inverted rC [3Inv-rC] Cytidine C 3′–3′ RNA structure, nuclease and folding studies
5′ Inverted rC [5Inv-rC] Cytidine C 5′–5′ RNA reverse-polarity architecture
3′ Inverted rG [3Inv-rG] Guanosine G 3′–3′ RNA structure and recognition studies
5′ Inverted rG [5Inv-rG] Guanosine G 5′–5′ RNA reverse-polarity architecture
3′ Inverted rU [3Inv-rU] Uridine U 3′–3′ RNA folding and modified-backbone studies
5′ Inverted rU [5Inv-rU] Uridine U 5′–5′ RNA reverse-polarity architecture

Inverted 2′-O-Methyl RNA Bases

Explicit 2OMe notation avoids confusion with 5-methylcytidine or other methylated bases.

Modification Example Sequence Code Sugar / Scaffold Base Linkage Typical Applications
3′ Inverted 2′-OMe A [3Inv-2OMeA] 2′-O-methyl adenosine A 3′–3′ siRNA, ASO, nuclease-resistance and cap designs
5′ Inverted 2′-OMe A [5Inv-2OMeA] 2′-O-methyl adenosine A 5′–5′ Reverse-polarity 2′-OMe designs
3′ Inverted 2′-OMe C [3Inv-2OMeC] 2′-O-methyl cytidine C 3′–3′ siRNA, ASO and modified RNA studies
5′ Inverted 2′-OMe C [5Inv-2OMeC] 2′-O-methyl cytidine C 5′–5′ Reverse-polarity 2′-OMe designs
3′ Inverted 2′-OMe G [3Inv-2OMeG] 2′-O-methyl guanosine G 3′–3′ ASO, RNA stability and recognition studies
5′ Inverted 2′-OMe G [5Inv-2OMeG] 2′-O-methyl guanosine G 5′–5′ Reverse-polarity 2′-OMe designs
3′ Inverted 2′-OMe U [3Inv-2OMeU] 2′-O-methyl uridine U 3′–3′ siRNA, ASO and nuclease-resistance studies
5′ Inverted 2′-OMe U [5Inv-2OMeU] 2′-O-methyl uridine U 5′–5′ Reverse-polarity 2′-OMe designs

Inverted Dideoxy Bases

Dideoxy reverse-polarity bases for strong blocking, adapter control and chain-termination designs.

Modification Example Sequence Code Sugar / Scaffold Base Linkage Typical Applications
3′ Inverted ddA [3Inv-ddA] 2′,3′-dideoxyadenosine A 3′–3′ Double chain termination and advanced blocking designs
5′ Inverted ddA [5Inv-ddA] 2′,3′-dideoxyadenosine A 5′–5′ Specialty adapter or reverse-polarity designs
3′ Inverted ddC [3Inv-ddC] 2′,3′-dideoxycytidine C 3′–3′ Double chain termination and blocking studies
5′ Inverted ddC [5Inv-ddC] 2′,3′-dideoxycytidine C 5′–5′ Specialty reverse-polarity constructs
3′ Inverted ddG [3Inv-ddG] 2′,3′-dideoxyguanosine G 3′–3′ Double chain termination and blocking studies
5′ Inverted ddG [5Inv-ddG] 2′,3′-dideoxyguanosine G 5′–5′ Specialty reverse-polarity constructs
3′ Inverted ddT [3Inv-ddT] 2′,3′-dideoxythymidine T 3′–3′ Strong terminal blocking and chain-termination designs
5′ Inverted ddT [5Inv-ddT] 2′,3′-dideoxythymidine T 5′–5′ Adapter blocking, ligation control and reverse-polarity design

Advanced Reverse-Polarity Chemistries

Advanced inverted analogs and therapeutic-style chemistries that should be reviewed as custom synthesis projects.

Modification Example Sequence Code Sugar / Scaffold Base Linkage Typical Applications
Inverted 2′-F A [Inv-2FA] 2′-fluoro adenosine A 3′–3′ or 5′–5′ Therapeutic-style RNA analog research
Inverted 2′-F C [Inv-2FC] 2′-fluoro cytidine C 3′–3′ or 5′–5′ Therapeutic-style RNA analog research
Inverted 2′-F G [Inv-2FG] 2′-fluoro guanosine G 3′–3′ or 5′–5′ Therapeutic-style RNA analog research
Inverted 2′-F U [Inv-2FU] 2′-fluoro uridine U 3′–3′ or 5′–5′ Therapeutic-style RNA analog research
Inverted LNA-A [Inv-LNA-A] Locked nucleic acid A 3′–3′ or 5′–5′ High-affinity reverse-polarity designs
Inverted LNA-C [Inv-LNA-C] Locked nucleic acid C 3′–3′ or 5′–5′ High-affinity reverse-polarity designs
Inverted LNA-G [Inv-LNA-G] Locked nucleic acid G 3′–3′ or 5′–5′ High-affinity reverse-polarity designs
Inverted LNA-T/U [Inv-LNA-T/U] Locked nucleic acid T/U 3′–3′ or 5′–5′ High-affinity reverse-polarity designs
Inverted 2′-MOE A [Inv-MOE-A] 2′-O-methoxyethyl adenosine A 3′–3′ or 5′–5′ ASO-style specialty chemistry
Inverted 2′-MOE C [Inv-MOE-C] 2′-O-methoxyethyl cytidine C 3′–3′ or 5′–5′ ASO-style specialty chemistry
Inverted 2′-MOE G [Inv-MOE-G] 2′-O-methoxyethyl guanosine G 3′–3′ or 5′–5′ ASO-style specialty chemistry
Inverted 2′-MOE U [Inv-MOE-U] 2′-O-methoxyethyl uridine U 3′–3′ or 5′–5′ ASO-style specialty chemistry

Inverted Abasic and Spacer Modifications

Non-base reverse-polarity residues for blocking, spacing, abasic-site models and distance control.

Modification Example Sequence Code Sugar / Scaffold Base Linkage Typical Applications
3′ Inverted abasic site [3Inv-Ab] THF / dSpacer-type abasic residue — 3′–3′ Polymerase blocking, abasic-site models and nuclease studies
5′ Inverted abasic site [5Inv-Ab] THF / dSpacer-type abasic residue — 5′–5′ Reverse-polarity abasic constructs
Reverse abasic phosphoramidite [Inv-Ab-PA] Abasic phosphoramidite — Reverse-polarity reagent Synthesis of inverted abasic linkages
3′ Inverted dSpacer [3Inv-dSp] Abasic dSpacer — 3′–3′ End blocking and abasic-site modeling
5′ Inverted dSpacer [5Inv-dSp] Abasic dSpacer — 5′–5′ Reverse-polarity abasic spacing
3′ Inverted Spacer C3 [3Inv-SpC3] C3 alkyl spacer — 3′–3′ Short non-nucleotide spacer and blocker
5′ Inverted Spacer C3 [5Inv-SpC3] C3 alkyl spacer — 5′–5′ Reverse-polarity spacer design
3′ Inverted Spacer C6 [3Inv-SpC6] C6 alkyl spacer — 3′–3′ Flexible spacer and terminal blocking
5′ Inverted Spacer C6 [5Inv-SpC6] C6 alkyl spacer — 5′–5′ Reverse-polarity spacer design
3′ Inverted Spacer C9 [3Inv-SpC9] C9 alkyl spacer — 3′–3′ Longer hydrophobic spacer
3′ Inverted Spacer C12 [3Inv-SpC12] C12 alkyl spacer — 3′–3′ Longer hydrophobic spacer
Inverted Spacer 18 / HEG [Inv-HEG] Hexaethylene glycol spacer — 3′–3′ or 5′–5′ Hydrophilic spacing, loop and distance-control designs

Sequence code note: The sequence codes shown are representative examples for illustration using Bio-Synthesis-style bracket notation. Bio-Synthesis can accommodate customer-preferred sequence annotation and ordering conventions, which may differ from other manufacturers or software platforms.

Availability notice: Bio-Synthesis supports a broad range of inverted base modifications for custom oligonucleotide synthesis. While many inverted DNA, RNA, dideoxy, abasic, spacer and reverse-polarity phosphoramidite building blocks are commercially available, some specialty modifications may not be readily available and may require custom reagent preparation or process development by Bio-Synthesis. Please contact our technical team to discuss sequence feasibility, modification compatibility and lead time for your specific project.

Reverse-Polarity Synthesis Capability

Reverse Synthesis Capability for Inverted-Base Oligos

Some inverted-base oligonucleotides require reverse (5′→3′) oligonucleotide synthesis using specialized reverse-polarity phosphoramidite chemistry. Bio-Synthesis provides the finished custom oligonucleotide product; we do not position this service as the sale of reverse phosphoramidite reagents or synthesis building blocks.

When Reverse Synthesis Is Needed

For many standard oligos, conventional phosphoramidite synthesis is sufficient. However, certain inverted-base, reverse-polarity, 3′–3′, 5′–5′, internal inversion, RNA, 2′-O-methyl, abasic, spacer, and chimeric designs may require a reverse synthesis strategy to place the desired linkage or terminal architecture correctly. In these cases, Bio-Synthesis evaluates the sequence, chemistry, polarity map, deprotection compatibility, purification method, and QC requirements before manufacturing the finished oligo.

Reverse Synthesis Capability Summary

This table describes finished-oligo synthesis capabilities, not reagent sales.

Capability Bio-Synthesis Support Design Notes
Reverse DNA synthesis Supported Used for reverse-polarity DNA, inverted DNA bases, and selected 3′–3′ or 5′–5′ architectures.
Reverse RNA synthesis Supported / project dependent Used for inverted RNA and reverse-polarity RNA designs when sequence and deprotection conditions are compatible.
Reverse 2′-O-methyl RNA synthesis Supported / project dependent Used for selected 2′-OMe reverse-polarity designs in siRNA, ASO, or modified RNA research applications.
3′–3′ linkage synthesis Supported Common for terminal inverted residues and selected internal reverse-polarity junctions.
5′–5′ linkage synthesis Supported Useful for reverse-polarity caps, adapter control, and specialty strand architectures.
Mixed forward / reverse synthesis strategy Project dependent May be required for internal inversions, chimeric oligos, or constructs with multiple polarity changes.
Inverted abasic and spacer designs Supported Used for blocking, spacing, abasic-site models, and non-nucleotide reverse-polarity segments.
Multiple reverse-polarity sites Project dependent Requires review of coupling efficiency, purification strategy, final mass, and analytical QC.
1

Customer Design

Sequence and desired inversion

2

Feasibility Review

Polarity, chemistry, scale

3

Synthesis Strategy

Forward, reverse, or mixed route

4

Custom Oligo Synthesis

Manufacture finished oligo

5

Purification

Desalt, HPLC, or PAGE

6

QC Release

Mass, purity, CoA

Related Technology Page

For a deeper discussion of 5′→3′ reverse oligonucleotide synthesis, reverse synthesis strategy, reverse-polarity manufacturing, and process considerations, link this section to the dedicated Reverse Oligonucleotide Synthesis page. This inverted-base page should stay focused on the modification and final oligo design.

Design Guidance

Design Considerations for Inverted Base Oligos

The best design depends on whether the goal is simple end blocking, nuclease resistance, ligation control, or a deliberate reverse-polarity backbone architecture.

END

Terminal Blocking

For polymerase blocking or 3′ exonuclease protection, a terminal 3′ inverted dT is usually the first-choice design because it is robust, familiar and widely supported.

INT

Internal Inversions

Internal inverted bases can create a structural interruption. Confirm sequence polarity, neighboring residues and final orientation carefully before synthesis.

CAP

5′ Reverse-Polarity Caps

5′ inverted bases and inverted ddT can be useful for adapter control, ligation suppression and specialized nucleic acid architectures.

Tm

Hybridization Effects

Terminal inverted residues usually have limited effects on upstream hybridization, while internal inverted residues may change duplex geometry and melting behavior.

RNA

RNA Reverse Synthesis

Reverse RNA synthesis with rA, rC, rG and rU phosphoramidites enables custom inverted RNA and chimeric RNA designs for structure-function studies.

QC

Analytical Confirmation

Complex inverted constructs should be confirmed by mass spectrometry and purified by HPLC or PAGE depending on length, chemistry and application.
Applications

Common Applications for Inverted Base Modified Oligos

PCR

PCR Probes

Block extension of hydrolysis probes, displacement probes and assay-specific oligos.
NGS

Sequencing Adapters

Reduce unwanted extension, ligation and concatemer artifacts in library workflows.
ASO

Antisense Oligos

Improve terminal stability and tune nuclease sensitivity in research-grade ASO designs.
APT

Aptamers

Protect terminal ends while preserving binding sequence architecture.
BLK

Blocking Oligos

Prevent extension from blockers used in PCR, enrichment, depletion or capture workflows.
NANO

DNA Nanotechnology

Create reverse-polarity junctions, caps and unusual strand architectures.
RNA

RNA Structure

Use custom inverted RNA or 2′-OMe residues to test polarity effects on folding.
DAMAGE

Abasic Models

Use inverted abasic or dSpacer residues for DNA damage, repair and polymerase studies.
Quality and Deliverables

Recommended Purification and QC

PUR

Purification

  • Desalt for simple screening oligos
  • RP-HPLC or IE-HPLC for many modified oligos
  • PAGE for high-resolution separation or long constructs
MS

Identity Confirmation

  • ESI-MS or MALDI-TOF recommended
  • Analytical HPLC trace where appropriate
  • CoA with modification annotation
DEL

Delivery Format

  • Lyophilized oligo in tubes or plates
  • Custom concentration or buffer by request
  • Sequence map showing inverted positions

Frequently Asked Questions

FAQ

What is an inverted base modified oligo?
 It is an oligonucleotide containing a nucleotide incorporated in reverse polarity, often creating a 3′–3′ or 5′–5′ linkage instead of a standard 5′→3′ backbone connection.
Is an inverted base the same as a 2′→5′ linkage?
 No. A 2′→5′ linkage changes the hydroxyl position used in the phosphodiester bond. An inverted base changes nucleotide polarity and can create 3′–3′ or 5′–5′ connectivity.
Is inverted base the same as reverse synthesis?
 No. Reverse synthesis is a synthesis strategy or reagent approach. An inverted base is a structural feature of the final oligo.
What is 3′ inverted dT?
 3′ inverted dT is a terminal inverted deoxythymidine commonly used to block polymerase extension and protect the 3′ end from exonuclease digestion.
Can Bio-Synthesis perform reverse RNA synthesis?
 Yes. Bio-Synthesis can evaluate reverse RNA synthesis strategies for custom inverted RNA and reverse-polarity RNA oligonucleotide designs.
Can inverted bases be internal?
 Yes, but internal inverted bases are more complex than terminal inverted dT and require careful design of strand polarity and neighboring residues.
Can 2′-O-methyl inverted bases be synthesized?
 They may be feasible as custom synthesis projects, especially for advanced siRNA, ASO or nuclease-resistance studies.
What is inverted dideoxy-T used for?
 Inverted ddT can provide strong blocking behavior and is often considered for adapter, ligation-control or terminal architecture designs.
Can inverted bases be combined with phosphorothioates?
 Often yes, but compatibility depends on sequence, placement, scale and vendor capability. Complex designs should be reviewed before ordering.
What QC should I request?
 For most modified oligos, request HPLC or PAGE purification with mass spectrometry identity confirmation.
More FAQ'sAll FAQ's
Before Requesting a Quote

Information Helpful for Inverted Base Oligo Designs

Goal
blocking, stability, reverse polarity
Sequence
5′→3′ and polarity map
Modification
Inv-dT, ddT, RNA, abasic
Position
3′ end, 5′ end, internal
Scale
nmol, µmol, mg, g
QC
HPLC, LC-MS, PAGE, CoA
Contact & Quote Request

Need help designing an inverted base or reverse-polarity oligo?

Share your sequence, desired inverted residue, exact modification position, 3′–3′ or 5′–5′ orientation, chemistry type, scale, purification and QC requirements. For internal, multiple-inversion, RNA, 2′-O-methyl or chimeric designs, include an annotated sequence or polarity map so Bio-Synthesis can evaluate manufacturability and reagent requirements.
Request a Quote Speak to a Scientist

Need help before quoting?

Email: info@biosyn.com
Phone: 800-227-0627 (US/CAN)
Phone: +001-972-420-8505 (INT)
RP

Reverse-Polarity Revieww

Evaluate 3′–3′ and 5′–5′ linkage placement, reverse synthesis route, reagent availability and sequence feasibility.

3′–3′ 5′–5′ Inv dT Inv ddT
QC

Release Package

Purification, mass confirmation, analytical purity, concentration, sequence annotation and documentation.

HPLC LC-MS PAGE CoA
Recommended Reading

Recommended Reading & Technical Background

Use this section to support scientific credibility while keeping the page focused on inverted base chemistry, reverse-polarity synthesis, terminal blocking, nuclease resistance and analytical verification.

  1. Letsinger RL, Wu T. Control of oligonucleotide polarity by reverse phosphoramidite synthesis and reverse-polarity linkages. Foundational concepts for 3′–3′ and 5′–5′ oligonucleotide architecture.
  2. Glen Research technical resources. Reverse synthesis phosphoramidites and 5′-CE phosphoramidites. Practical background on reverse-polarity DNA synthesis and specialized solid supports.
  3. Crooke ST, Liang XH, Baker BF, Crooke RM. Antisense technology: a review. Journal of Biological Chemistry. 2021. Background for terminal stabilization and modified oligonucleotide design.
  4. Beaucage SL, Caruthers MH. Deoxynucleoside phosphoramidites—A new class of key intermediates for deoxypolynucleotide synthesis. Tetrahedron Letters. 1981. Core phosphoramidite chemistry supporting specialty oligo synthesis.
  5. Hermanson GT. Bioconjugate Techniques. Academic Press. Useful background for combining inverted oligos with functional handles, labels and conjugation strategies.
  6. Selected vendor technical bulletins. Reverse RNA synthesis, reverse abasic phosphoramidites and specialty modified oligonucleotides. Useful for evaluating RNA, 2′-O-methyl and abasic reverse-polarity designs.

Suggested page note: References are provided for scientific background. Final inverted-base oligo design should be evaluated within the sequence, polarity, modification placement, deprotection compatibility, purification method and QC requirements.

Why Choose Bio-Synthesis

Trusted by biotech leaders worldwide for over 45+ years of delivering high quality, fast and scalable synthetic biology solutions.

Greetings Researchers,

Please be advised that any information, guidelines, writeups, and oral/video/graphic content on our website are intended solely as general guidelines.
It is the researcher's sole responsibility to conduct thorough research on the designs of the products intended for their experiments before submitting
their designs to Biosynthesis for review of production feasibility.
Thank you for your understanding.

Quick Links